Dyslipidemias in Patients Who Have Chronic Kidney Disease
- 31 May 2005
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 89 (3) , 689-699
- https://doi.org/10.1016/j.mcna.2004.11.002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialPublished by Elsevier ,2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart DiseaseJAMA, 1998
- EFFECTS OF TACROLIMUS ON HYPERLIPIDEMIA AFTER SUCCESSFUL RENAL TRANSPLANTATIONTransplantation, 1998
- Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failureAmerican Journal of Kidney Diseases, 1997
- Lipids and the kidneyKidney International, 1994
- Lipoprotein Metabolism and Renal FailureAmerican Journal of Kidney Diseases, 1993
- Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuriaKidney International, 1991
- Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between FacilitiesAmerican Journal of Kidney Diseases, 1990